The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation
Key Clinical Message: In infants, especially with novel previously undescribed mutations of the KATP channel causing neonatal diabetes, in vitro studies can be used to both predict the response to sulphonylurea treatment and support a second trial of glibenclamide at higher than standard doses if th...
Hlavní autoři: | O'Connell, S, Proks, P, Kramer, H, Mattis, K, Sachse, G, Joyce, C, Houghton, J, Ellard, S, Hattersley, A, Ashcroft, F, O'Riordan, S |
---|---|
Médium: | Journal article |
Vydáno: |
John Wiley and Sons Ltd
2015
|
Podobné jednotky
-
Molecular basis of Kir6.2 mutations causing neonatal diabetes and neonatal diabetes with neurological features
Autor: Proks, P, a další
Vydáno: (2005) -
Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
Autor: Proks, P, a další
Vydáno: (2004) -
Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms.
Autor: Männikkö, R, a další
Vydáno: (2010) -
Permanent neonatal diabetes caused by an in-frame deletion in the N-terminus of Kir6.2
Autor: Craig, T, a další
Vydáno: (2008) -
Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
Autor: Shimomura, K, a další
Vydáno: (2006)